• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ANR

ANATARA LIFESCIENCES LTD - Charts / Financials

0.00% ! 1.0¢
Market Cap $3.159M  !

Anatara Lifesciences Ltd is an Australia-based company focused on developing oral... Anatara Lifesciences Ltd is an Australia-based company focused on developing oral solutions for gastrointestinal diseases in production animals and humans and the development and commercialization of Detach, a non-antibiotic therapy that prevents and treats diarrhea (scour) in piglets. Detach is a modified release formulation of BromelainRx, a natural extract from pineapple stems. Detach helps in address the overuse of antibiotics in animals. It is formulated with various ingredients to allow oral administration and delivery to the small intestine. The Company is focused on developing Detach for pigs in Australia and then expanding the program to Europe and the United States. The Company is also developing a similar version of Detach to prevent diarrhea in humans. The Company is seeking to collaborate with pharmaceutical/biotechnology companies for clinical development and commercialization of a similar version of Detach for human application in travelers and military personnel.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

refresh Created with Sketch. REFRESH
Day chart unavailable
Last update - 10.00am 30/07/2026 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
0 1.0¢ 0   0 1.0¢ 0

Directors & Senior Management

Dr. David Lionel Brookes Executive Chairman & MD
Mr. Dirk van Dissel Independent Non-Executive Director
Ms. Hayley van der Meer Commercial Manager
Dr. Jakob Begun Member of Product Development Advisory Board
Mr. John Michailidis Non-Executive Director
Mr. Jonathan Lindh Company Secretary
Prof. Peter Gibson Chairman of Product Development Advisory Board
Dr. Rebecca Burgell Member of Product Development Advisory Board
Mr. Simon Erskine Chief Development Officer
Dr. Simon Keely Member of Product Development Advisory Board

Data source: ADVFN

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $3.159M
Open High Low Volume
0.0¢ 0.0¢ 0.0¢ 0
Last trade - 10.00am 30/07/2026 (20 minute delay) ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.